myNEO Therapeutics selected as Rising Star!
6 October 2021

myNEO Therapeutics has been nominated for the 2021 Rising Star award, together with 9 other innovative companies!

The Rising Star selection is part of the Deloitte Technology Fast 50 competition and is designed for promising companies that have been active in the technology sector for less than four years. Bert Coessens, together with the representatives of the other 9 nominated companies, will participate in a pitch presentation on 25 November 2021. An independent jury will select the 2021 Rising Star.

“To be nominated as one of the Rising Stars is, for us, another strong validation that myNEO Therapeutics’ business and vision are more relevant than ever within oncology and healthcare. It is a great honor to be nominated.” – Bert Coessens, COO

About Rising Star Award

The Deloitte Technology Fast 50 competition is an annual selection of the 50 fastest growing and innovative technology companies headquartered and founded in Belgium. Public or private companies who develop a technology related product or service and who have experienced substantial revenue growth over the last four years can enter the competition for their chance to be nominated as one of the 50 fastest-growing technology companies in Belgium.

Companies that have been active in the technology sector for less than four years can participate in the special Rising Star category of the competition. These companies are judged by an independent jury on their turnover potential and scalability.

Participating in the Rising Star competition can help companies to develop their business by increasing their visibility and giving them access to the Fast 50’s unique network of highly successful executives.